Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 32589698 | HLA-CLASS II (HLA CLASS II) | hodgkin lymphoma | NA | NA | NA | unclassified | |
| rosetting t cells in hodgkin lymphoma are activated by immunological synapse components hla class ii and cd58. | |||||||
| 34530573 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hodgkin lymphoma | NA | NA | NA | unclassified | |
| the immune evasion mechanisms in hodgkin lymphoma include a reduction of human leukocyte antigen (hla) to affect first signal which is essential for t cell activation | |||||||
| 8124417 | HLA-B*51 | chicken pox | NA | NA | NA | unclassified | |
| recent attention has focused on the hla-b51 antigen and chicken pox as possible risk factors. | |||||||
| 8127833 | HLA (HLA) | joint tuberculosis | NA | NA | NA | unclassified | |
| [immune status in patients with bone and joint tuberculosis and effect of hla genotype]. | |||||||
| 8134177 | HLA-DR (HLA-DR) | bronchopulmonary dysplasia | NA | NA | NA | unclassified | |
| increased expression of human leukocyte antigen-dr on pulmonary macrophages in bronchopulmonary dysplasia. | |||||||
| 8134177 | HLA-DR (HLA-DR) | bronchopulmonary dysplasia | NA | NA | NA | unclassified | |
| we used an immunoperoxidase method to examine the expression of the immune activation marker hla-dr on pulmonary tissue obtained at autopsy from 14 patients dying of bronchopulmonary dysplasia. | |||||||
| 22045425 | HLA (HLA) | bronchopulmonary dysplasia | NA | NA | NA | unclassified | |
| hla and bronchopulmonary dysplasia susceptibility: a pilot study. | |||||||
| 22045425 | HLA (HLA) | bronchopulmonary dysplasia | NA | NA | NA | unclassified | |
| there is little data on the association between human leucocyte antigen (hla) alleles and bronchopulmonary dysplasia (bpd) of the preterm newborn. | |||||||
| 8146803 | HLA-B*14 | cholecystitis | NA | NA | NA | unclassified | |
| studies into the genealogical anamnesis and a number of genetic characteristics of patients with chronic cholecystitis allowed one to confirm the significance of hereditary burden in the development of cholecystitis and to identify genetic markers (b(iii) blood group), type hp 1-1, hla a3, hla a30 and hla b5, as well genetic protectors (o(i) blood group), hla b8, hla b14 of the disease. | |||||||
| 8146803 | HLA-A*30 | cholecystitis | NA | NA | NA | unclassified | |
| studies into the genealogical anamnesis and a number of genetic characteristics of patients with chronic cholecystitis allowed one to confirm the significance of hereditary burden in the development of cholecystitis and to identify genetic markers (b(iii) blood group), type hp 1-1, hla a3, hla a30 and hla b5, as well genetic protectors (o(i) blood group), hla b8, hla b14 of the disease. | |||||||
Copyright 2024